You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Best Practices in Improving Glycemic Control and Reducing CV Risk: Multispecialty Team Perspectives

  • Authors: Carol Wysham, MD; Christopher Cannon, MD; Jay Shubrook, DO; Tory Lucas, RN, CDE
  • CME / ABIM MOC / CE Released: 11/19/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 11/19/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for diabetologists & endocrinologists, cardiologists, primary care physicians, nurses, nurse practitioners, physician assistants, and others involved in the management of patients with type 2 diabetes (T2D) and elevated cardiovascular (CV) risk.

The goal of this activity is to improve CV risk reduction in patients with T2D.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Guideline-based strategies to improve glycemic control and reduce CV risk in patients with T2D and CV disease (CVD) 
  • Have greater competence related to
    • Using team-based management of patients with T2D and CVD
    • Improving individualized and comprehensive management of patients with T2D and CVD 


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

All of the relevant financial relationships listed for these individuals have been mitigated.


Moderator

  • Carol Wysham, MD

    Clinical Professor of Medicine
    University of Washington School of Medicine
    Rockwood/MultiCare Center for Diabetes and Endocrinology
    Spokane, Washington

    Disclosures

    Disclosure: Carol Wysham, MD, has the following relevant financial relationships: 
    Advisor or consultant for: Abbott; Novo Nordisk; Sanofi
    Speaker or a member of a speakers bureau for: Astra Zeneca; Boehringher Ingelheim; Eli Lilly; Janssen; Novo Nordisk; Sanofi
    Grants for clinical research from: Abbott; Gilead; Corcept; Novo Nordisk; Milan; Eli Lilly

Panelists

  • Christopher Cannon, MD

    Education Director, Cardiovascular Innovation
    Preventive Cardiology Section, Brigham and Women’s Hospital
    Professor of Medicine, Harvard Medical School
    Boston, Massachusetts

    Disclosures

    Disclosure: Christopher Cannon, MD, has the following relevant financial relationships: 
    Advisor or consultant for: Aegerion/Amryt; Alnylam; Amarin; Amgen; Applied Therapeutics; Ascendia; Boehringer-Ingelheim; Bristol-Myers Squibb; Eli Lilly; Janssen; Lexicon; Merck; Pfizer; Rhoshan; Sanofi
    Grants for clinical research from: Amgen; Better Therapeutics; Boehringer-Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen; Merck; Novo Nordisk; Pfizer
    Other: Serve on Data and Safety Monitoring Boards for the Applied Therapeutics; Novo Nordisk

  • Jay Shubrook, DO

    Professor of Medicine
    Touro University California
    Vallejo, California

    Disclosures

    Disclosure: Jay Shubrook, DO, has the following relevant financial relationships: 
    Advisor or consultant for: Abbott; Astras Zeneca; Bayer; NovoNordisk

Author HCP

  • Tory Lucas, RN, CDE

    Nurse
    Rockwood/MultiCare Center for Diabetes and Endocrinology
    Spokane, Washington

    Disclosures

    Disclosure: Tory Lucas RN, CDE, has disclosed no relevant financial relationships.

Editors

  • Anne G. Le, PharmD

    Senior Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Anne G. Le, PharmD, has disclosed no relevant financial relationships.

  • Gina Montanero, PharmD

    Associate Medical Writer

    Disclosures

    Disclosure: Gina Montanero, PharmD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.75 contact hour(s) nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Best Practices in Improving Glycemic Control and Reducing CV Risk: Multispecialty Team Perspectives

Authors: Carol Wysham, MD; Christopher Cannon, MD; Jay Shubrook, DO; Tory Lucas, RN, CDEFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC / CE Released: 11/19/2021

Valid for credit through: 11/19/2022

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Best Practices in Improving Glycemic Control and Reducing CV Risk: Multispecialty Team Perspectives

A multidisciplinary expert panel discuss how team-based care can improve CV risk reduction in patients with type 2 diabetes.
Carol Wysham, MD; Christopher Cannon, MD; Jay Shubrook, DO

Nurses’ Role in Glycemic Management and CV Risk Reduction

Read about nurse-centric strategies for cardiovascular risk reduction in T2D management.
Tory Lucas, RN, CDE

Pre-Assessment Survey

Before you begin, please take this brief survey.